Celldex Therapeutics (CLDX) is a biopharmaceutical company, which applies its Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. This stock is trading up 4.1% to $4.79 in recent trading.
Today's Range: $4.65-$4.8952-Week Range: $2.05-$5.66 Volume: 866,000 Three-Month Average Volume: 825,854 From a technical perspective, CLDX is moving sharply higher today on decent volume. This move has now pushed CLDX within range of triggering a near-term breakout. That breakout will hit once some overhead resistance at $5.19 is taken out with volume. Traders should look for long biased trades if $5.19 is taken out with volume that's near or well above 825,854 shares. If we get that action soon, then look for CLDX to re-test its next significant overhead resistance level at $5.66 in the near future. Celldex shows up on a recent list of 7 Cancer Drug Stocks to Know Right Now.